Fetal and Neonatal Heart Monitor Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028

Published on : May-2018 | List of Tables : 108 | List of Figures : 164 | No. of Pages : 170 | Report Code : FACT750MR | Format : ppt pdf Excel Word

Preterm birth is one of the most prevalent cause of stillbirths, or fetal mortality, and neonatal morbidity & mortality. In the U.S. alone, premature births account for nearly 10% of the newborn babies annually. Insufficient and improper nutrition delivery, a primary cause of preterm birth, has been lined with many health diseases and cardiovascular malignancies. Increase in the number of stillbirths on the coattails of preterm birth has raised concerns with regard to safety monitoring, such as heart rate monitoring.

Alterations in readings of heart rate in conventional fetal and neonatal heart monitor has created confusion among clinicians and patients in the past. False readings have further misled diagnosis and treatment, thereby posing high risk to fetus. Recognizing the concern, fetal and neonatal heart monitor manufacturers have introduced novel solutions in order to prevent false diagnosis and avoid ambiguities. Smart pulse fetal heart monitoring technology developed by Philips is one such novel development perceived in the market. This report envisages the fetal and neonatal heart monitor market to record a steady 5.5% value CAGR in the period of forecast, 2018 to 2028.

fetal and neonatal heart monitor market

Opportunities Abound in Fetal and Neonatal Heart Monitors for Metabolic Disorder Induced Risks

Despite intensive efforts taken for interpretation of fetal and neonatal heart rate to prevent hypoxia, challenges prevail regarding complete diagnosis of heart rate pattern changes, particularly caused by metabolic disorders. New research approaches are being introduced for facilitating care of fetal and neonatal hypoxia cost-effectively, as a means to alleviate expensive and complication procedure related to computerized Cardiotocograph (CTG).

One of these approaches is to assess mobile resuscitation devices, which are particularly designed for simplifying newborn resuscitation at bedside through an intact cord, as iatrogenic interference with “auto-resuscitation” occurs post-separation of newborn babies from their placental transfusion. Another effective approach the use of CO breath analyzers during the period of labor, which is easy-to-use, speedy, and non-invasive technology. This technology enables identifying most frequent conditions causing metabolic academia and hypoxia.

Vested interest and rigid mindset of equipment manufacturers who seek lucrative medico-legal practices point at over-longstanding dependency on CTG. However, new research approaches being introduced have paved new avenues for manufacturers of fetal and neonatal heart monitor.

Fetal and Neonatal Heart Monitor: Novel Modality Developments Offering Framework for Non-Invasive Evaluation

Healthcare professionals recommend intrapartum fetal heart rate (FHR) monitor during labor for proper assessment of fetal wellbeing. Despite high penetration, fetal scalp electrode monitor and external Doppler have been deemed to have significant shortcomings, which in turn has led toward the development of non-invasive modality technologies as possible alternatives. Intrapartum fetal heart rate monitoring using Electronic Uterine Monitoring (EUM) is considered to be a notable development in the field.

Comparative analysis carried out between accuracy of FHR trace via novel EUM, and fetal scalp electrode monitor and external Doppler has shown accuracy of the former to be significant higher. Intrapartum FHR via EUM has been proved to be accurate and valid, offering higher yields in correlations with the internal scalp electrode monitoring and external Doppler. Such novel modality developments are likely to impart greater framework for intrapartum FHR’s non-invasive evaluation.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Fact.MR’s recently published report propounds valuable insights and accurate forecasts on the fetal and neonatal heart monitor market for the period of forecast, 2018 to 2028. Key parameters such as impact of current and future growth determinants & deterrents, expected developments & regulatory scenario, demand statistics, and raw material procurement & supply are elucidated and analyzed. Influence of these parameters on the fetal and neonatal heart monitor market’s growth has been quantified for deriving a market growth rate estimate.

Fetal and Neonatal Heart Monitor Market Taxonomy & Segmentation Analysis

This report also offers a scrutinized study on the market for fetal and neonatal heart monitor in terms of a segmentation analysis. The market has been divided into five key segments, viz., product type, end-user, modality, and region. These segments have been analyzed in detail, engulfing market forecasts and estimates at a country and regional level.

The segmentation analysis offered can be useful for the report readers in understanding probable opportunities and potential markets for the target product – fetal and neonatal heart monitor. A taxonomy table incorporated in the report illustrates all the market segments in a systematic manner as depicted below.

Region

Product Type

Modality

End-User

North America

Cardiotocograph

Table Top Devices

Hospitals

Latin America

Doppler

Portable and Hand Held Devices

Neonatal Clinics

Europe

Accessories

 

Ambulatory Surgical Centers

Japan

 

 

Diagnostic Centers

APEJ

 

 

 

MEA

 

 

 

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Competitive Landscape Assessment on Fetal and Neonatal Heart Monitor Market

In its concluding chapter, the report quantifies revenues share of prominent companies in the fetal and neonatal heart monitor market, and offers an in-depth overview of the market’s competitive scenario. A detailed description has been delivered on all the market players profiled in the report, which includes intelligence in terms of their company overview, key financials, product overview, past as well as latest developments.

A SWOT analysis on each market player profiled has been incorporated in the report, along with information on their new product developments, and market expansion strategies such as collaborations and partnerships. The scope of the report is offer its readers with authentic information and insights on the fetal and neonatal heart monitor market, to enable them in making better future decisions for growth of the businesses.

Robust Research Methodology to Provide Authentic Market Intelligence

A tested & proven research approach is employed by analysts at Fact.MR for evaluating key industry dynamics and offering precise and authentic market intelligence. A blend of primary & secondary research has been implemented for offering estimates and forecasts on the fetal and neonatal heart monitor market.

Secondary research forms initial phase of our research, wherein the analysts conduct extensive information mining by referring to up-to-date and verified data resources that include technical journals, regulatory and government published material, and independent studies, which forms the basis of the market estimates.

All the market estimates and forecast offered are further verified via an exhaustive primary research, wherein interviews are conducted with leading market participants, and industry experts. These comprehensive primary interviews aid in validating the information procured and gain significant industry insights, estimations and key developments.

1. Global Fetal and Neonatal Heart Monitor Market Executive Summary
1.1. Executive Summary
1.2. Highlighting Action Area – Wheel of Fortune 
1.3. Opportunity Analysis

2. Global Fetal and Neonatal Heart Monitor Market Overview
2.1. Introduction
2.2. Market Definition
2.3. Market Taxonomy and Segments Captured
2.4. Global Neonatal Mortality Rate Since 2000
2.5. Neonatal Mortality Rates By Region 2016
2.6. Major Reasons Behind Neonatal Deaths
2.7. Top 20 Countries With Lowest Infant Mortality Rate In 2017 (Child Deaths in the First Year Of Life Per 1,000 Live Births)
2.8. Major Causes For Fetal Death
2.9. Top 10 Countries With The Greatest Number Of Preterm Births Vs. Top 10 Countries With The Highest Rate Of Preterm Birth Per 100 Live Births, 2018
2.10. Global Fetal and Neonatal Heart Monitor Market – PEST Analysis
2.11. Porter’s Five Forces Analysis
2.12. Grades of Neonatal Care
2.13. Global Neonatal Monitoring Equipment Market – Scenario Forecast (US$ Mn), 2017–2028

3. Global Fetal and Neonatal Heart Monitor Market Overview 
3.1. Global Fetal and Neonatal Heart Monitor Market Value & Volume Forecast and Analysis, 2013 - 2028
3.2. Global Fetal and Neonatal Heart Monitor Market Value and Volume Forecast, by Region, 2018 - 2028
3.3. Fetal and Neonatal Heart Monitor Market Forecast Factors

4. Global Fetal and Neonatal Heart Monitor Market Dynamics
4.1. Fetal and Neonatal Heart Monitor Market Drivers
4.2. Fetal and Neonatal Heart Monitor Market Restraints
4.3. Fetal and Neonatal Heart Monitor Market Opportunities
4.4. Fetal and Neonatal Heart Monitor Market Trends

5. Global Fetal and Neonatal Heart Monitor Market Analysis Pricing Analysis and Supply Chain
5.1.  Pricing Analysis – Region Wise
5.2. Supply Chain

6. Global Fetal and Neonatal Heart Monitor Market Analysis and Forecast By Product Type, 2013-2028
6.1. Analysis and Forecast By Product Type
       6.1.1. Revenue (US$ Mn) & Volume (Units) Comparison, By Region
       6.1.2. Market Share Comparison, By Region
       6.1.3. Y-o-Y growth Comparison, By Region
6.2. Analysis and Forecast By End User
       6.2.1. Revenue (US$ Mn) & Volume (Units) Comparison, By Region
       6.2.2. Market Share Comparison, By Region
       6.2.3. Y-o-Y growth Comparison, By Region
6.3. Analysis and Forecast By Modality
       6.3.1. Revenue (US$ Mn) & Volume (Units) Comparison, By Region
       6.3.2. Market Share Comparison, By Region
       6.3.3. Y-o-Y growth Comparison, By Region
6.4. Analysis and Forecast By Region
       6.4.1. Revenue (US$ Mn) & Volume (Units) Comparison, By Region
       6.4.2. Market Share Comparison, By Region
       6.4.3. Y-o-Y growth Comparison, By Region

7. North America Fetal and Neonatal Heart Monitor Market Analysis, 2013-2028
7.1. Revenue (US$ Mn) & Volume (Units) Comparison, By Country
       7.1.1. U.S. Market Size & Forecast Value (US$ Mn) & Volume (Units)
       7.1.2. Canada Market Size & Forecast Value (US$ Mn) & Volume (Units)
7.2.  Revenue (US$ Mn) & Volume (Units), By Product Type
7.3. Revenue (US$ Mn) & Volume (Units), By End User
7.4. Revenue (US$ Mn) & Volume (Units), By Modality

8. Latin America Fetal and Neonatal Heart Monitor Market Analysis, 2013-2028
8.1. Revenue (US$ Mn) & Volume (Units), By Country
       8.1.1. Brazil Market Size & Forecast Value (US$ Mn) & Volume (Units)
       8.1.2. Mexico Market Size & Forecast Value (US$ Mn) & Volume (Units)
       8.1.3. Rest of Latin America Market Size & Forecast Value (US$ Mn) & Volume (Units)
8.2.  Revenue (US$ Mn) & Volume (Units), By Product Type
8.3. Revenue (US$ Mn) & Volume (Units), By End User
8.4. Revenue (US$ Mn) & Volume (Units), By Modality

9. Europe Fetal and Neonatal Heart Monitor Market Size and Forecast, 2013-2028
9.1. Revenue (US$ Mn) & Volume (Units) Comparison, By Country 
       9.1.1. Germany Market Size and Forecast Value (US$ Mn) & Volume (Units)
       9.1.2. UK Market Size and Forecast Value (US$ Mn) & Volume (Units)
       9.1.3. France Market Size and Forecast Value (US$ Mn) & Volume (Units)
       9.1.4. Spain Market Size and Forecast Value (US$ Mn) & Volume (Units)
       9.1.5. Italy Market Size and Forecast Value (US$ Mn) & Volume (Units)
       9.1.6. Rest Of Europe Market Size and Forecast Value (US$ Mn) & Volume (Units)
9.2. Revenue (US$ Mn) & Volume (Units) Comparison, By Product Type 
9.3. Revenue (US$ Mn) & Volume (Units) Comparison, By End User 
9.4. Revenue (US$ Mn) & Volume (Units) Comparison, By Modality 

10. Japan Fetal and Neonatal Heart Monitor Market Size and Forecast, 2013-2028
10.1. Japan Market Size and Forecast Value (US$ Mn) & Volume (Units)
10.2. Revenue (US$ Mn) & Volume (Units) Comparison, By Product Type 
10.3. Revenue (US$ Mn) & Volume (Units) Comparison, By End User 
10.4. Revenue (US$ Mn) & Volume (Units) Comparison, By Modality 

11. APEJ Fetal and Neonatal Heart Monitor Market Size and Forecast, 2013-2028
11.1. Revenue (US$ Mn) & Volume (Units) Comparison, By Country 
       11.1.1. China Market Size and Forecast Value (US$ Mn) & Volume (Units)
       11.1.2. India Market Size and Forecast Value (US$ Mn) & Volume (Units)
       11.1.3. Malaysia Market Size and Forecast Value (US$ Mn) & Volume (Units)
       11.1.4. Singapore Market Size and Forecast Value (US$ Mn) & Volume (Units)
       11.1.5. Australia & New Zealand  Market Size and Forecast Value (US$ Mn) & Volume (Units)
       11.1.6. Rest of APEJ Market Size and Forecast Value (US$ Mn) & Volume (Units)
11.2. Revenue (US$ Mn) & Volume (Units) Comparison, By Product Type 
11.3. Revenue (US$ Mn) & Volume (Units) Comparison, By End User 
11.4. Revenue (US$ Mn) & Volume (Units) Comparison, By Modality 

12. MEA Fetal and Neonatal Heart Monitor Market Size and Forecast, 2013-2028
12.1. Revenue (US$ Mn) & Volume (Units) Comparison, By Country 
       12.1.1. GCC Market Size and Forecast Value (US$ Mn) & Volume (Units)
       12.1.2. South Africa Market Size and Forecast Value (US$ Mn) & Volume (Units)
       12.1.3. Israel Market Size and Forecast Value (US$ Mn) & Volume (Units)
       12.1.4. Rest of MEA Market Size and Forecast Value (US$ Mn) & Volume (Units)
12.2. Revenue (US$ Mn) & Volume (Units) Comparison, By Product Type 
12.3. Revenue (US$ Mn) & Volume (Units) Comparison, By End User 
12.4. Revenue (US$ Mn) & Volume (Units) Comparison, By Modality 

13. Competition Landscape, Company Share and Company Profiles
13.1. Company Share Analysis and Industry Structure 
13.2. Competition Dashboard
13.3. Company Profiles
       13.3.1. General Electric Healthcare Limited
                 13.3.1.1. Company Overview 
                 13.3.1.2. Key Segmental Revenue Analyzed 
                 13.3.1.3. Company Strategic Assessment 
                 13.3.1.4. Channel Strategy 
                 13.3.1.5. SWOT Analysis 
       13.3.2. Drägerwerk AG & Co. KGaA
                 13.3.2.1. Company Overview 
                 13.3.2.2. Key Segmental Revenue Analyzed 
                 13.3.2.3. Company Strategic Assessment 
                 13.3.2.4. Channel Strategy 
                 13.3.2.5. SWOT Analysis 
       13.3.3. Getinge AB
                 13.3.3.1. Company Overview 
                 13.3.3.2. Key Segmental Revenue Analyzed 
                 13.3.3.3. Company Strategic Assessment 
                 13.3.3.4. Channel Strategy 
                 13.3.3.5. SWOT Analysis 
       13.3.4. Koninklijke Philips N.V.
                 13.3.4.1. Company Overview 
                 13.3.4.2. Key Segmental Revenue Analyzed 
                 13.3.4.3. Company Strategic Assessment 
                 13.3.4.4. Channel Strategy 
                 13.3.4.5. SWOT Analysis 
       13.3.5. Natus
                 13.3.5.1. Company Overview 
                 13.3.5.2. Key Segmental Revenue Analyzed 
                 13.3.5.3. Company Strategic Assessment 
                 13.3.5.4. Channel Strategy 
                 13.3.5.5. SWOT Analysis 
       13.3.6. Other Public and Private Players

14. Key Takeaways

15. Research Methodology

16. Disclaimer

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Fetal and Neonatal Heart Monitor Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028